66 related articles for article (PubMed ID: 3613164)
1. [Problems in measuring the activity of alpha 2-plasmin inhibitor in the urokinase therapy].
Moriyama H; Minami S; Okamoto K; Tsuchiya T; Tsuji K; Higashi T
Rinsho Byori; 1987 Apr; 35(4):465-7. PubMed ID: 3613164
[No Abstract] [Full Text] [Related]
2. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
Perides G; Noring R; Klempner MS
Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
[TBL] [Abstract][Full Text] [Related]
3. Binding and activation of plasminogen at the surface of human keratinocytes.
Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
[TBL] [Abstract][Full Text] [Related]
4. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
[TBL] [Abstract][Full Text] [Related]
5. Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions.
Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
Ann Otol Rhinol Laryngol; 1985; 94(3):293-6. PubMed ID: 3925865
[TBL] [Abstract][Full Text] [Related]
6. Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot.
Takada A; Ito T; Takada Y
Thromb Haemost; 1980 Feb; 43(1):20-3. PubMed ID: 6447383
[TBL] [Abstract][Full Text] [Related]
7. Plasmin inhibitors in different fibrinolytic treatment patterns.
Lasierra J; Diez M; Perera C; Viladés E
Haemostasis; 1981; 10(1):51-62. PubMed ID: 6162721
[TBL] [Abstract][Full Text] [Related]
8. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of measuring alpha2-plasmin inhibitor levels in kidney diseases].
Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Mizuhara H; Kawai S; Kuratsuji T; Shimizu K
Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1035-43. PubMed ID: 6668744
[No Abstract] [Full Text] [Related]
10. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
[TBL] [Abstract][Full Text] [Related]
11. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
[TBL] [Abstract][Full Text] [Related]
12. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
13. [Primary nephrotic syndrome treated with urokinase--a report of 20 cases].
Wang LS; Chen EH; Zhou XJ
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):356-9, 382. PubMed ID: 2582915
[TBL] [Abstract][Full Text] [Related]
14. Binding of urokinase to plasma proteinase inhibitors.
Holmberg L; Lecander I; Astedt B
Scand J Clin Lab Invest; 1980; 40(8):743-7. PubMed ID: 6169139
[TBL] [Abstract][Full Text] [Related]
15. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.
Collen D
Thromb Haemost; 1980 Jun; 43(2):77-89. PubMed ID: 6450468
[No Abstract] [Full Text] [Related]
16. Variations of alpha 2-plasmin inhibitor, antithrombin III, plasminogen in the serum of patients of cerebral thrombosis infused with urokinase.
Takada A; Takada Y; Uemura K; Nakajima S; Ryu H; Ninchoji T
Thromb Res; 1979; 15(5-6):889-94. PubMed ID: 115108
[No Abstract] [Full Text] [Related]
17. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
[TBL] [Abstract][Full Text] [Related]
18. [Problems in urokinase therapy in cerebral infarction].
Matsuo T; Matsuo O
Rinsho Ketsueki; 1978 Oct; 19(10):1475-8. PubMed ID: 739610
[No Abstract] [Full Text] [Related]
19. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
